The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Journal: Nature Immunology

Published: 2020-08-31

DOI: 10.1038/s41590-020-0769-3

Affiliations: 10

Authors: 31

Go to article
Institutions Share
National Cancer Center Research Institute (NCCRI), Japan 0.40
National Cancer Center Hospital East, Japan 0.32
Graduate School / School of Medicine, Nagoya University, Japan 0.15
Hitachi, Ltd., Japan 0.06
National Cancer Center Hospital, Japan 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER